These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23751769)

  • 1. A multicenter surveillance of antimicrobial resistance in Serratia marcescens in Taiwan.
    Liou BH; Duh RW; Lin YT; Lauderdale TL; Fung CP;
    J Microbiol Immunol Infect; 2014 Oct; 47(5):387-93. PubMed ID: 23751769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan.
    Wu H; Wang JT; Shiau YR; Wang HY; Lauderdale TL; Chang SC;
    J Microbiol Immunol Infect; 2012 Apr; 45(2):120-6. PubMed ID: 22154599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance of Serratia marcescens causing blood stream infections in a large University Hospital in Bulgaria, an 8-year analysis (2016-2023).
    Radeva S; Niyazi D; Bozhkova M; Stoeva T
    Acta Microbiol Immunol Hung; 2024 Sep; 71(3):191-196. PubMed ID: 39088273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.
    Wang JT; Chen PC; Chang SC; Shiau YR; Wang HY; Lai JF; Huang IW; Tan MC; Lauderdale TL;
    BMC Infect Dis; 2014 Sep; 14():486. PubMed ID: 25192738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibilities and bacteriological characteristics of bovine Pseudomonas aeruginosa and Serratia marcescens isolates from mastitis.
    Ohnishi M; Sawada T; Hirose K; Sato R; Hayashimoto M; Hata E; Yonezawa C; Kato H
    Vet Microbiol; 2011 Dec; 154(1-2):202-7. PubMed ID: 21783330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the antibiotic resistance rates of
    Simsek M
    Niger J Clin Pract; 2019 Jan; 22(1):125-130. PubMed ID: 30666031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Institutional spread of clonally related Serratia marcescens isolates with a novel AmpC cephalosporinase (S4): a 4-year experience in Taiwan.
    Yu WL; Ko WC; Cheng KC; Chen HE; Lee CC; Chuang YC
    Diagn Microbiol Infect Dis; 2008 Aug; 61(4):460-7. PubMed ID: 18455901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010.
    Toh HS; Chuang YC; Huang CC; Lee YL; Liu YM; Ho CM; Lu PL; Liu CE; Chen YH; Wang JH; Ko WC; Yu KW; Liu YC; Chen YS; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S18-23. PubMed ID: 22749054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experiences of the infections caused by extended-spectrum beta-lactamase-producing Serratia marcescens at a medical center in Taiwan.
    Cheng KC; Chuang YC; Wu LT; Huang GC; Yu WL
    Jpn J Infect Dis; 2006 Jun; 59(3):147-52. PubMed ID: 16785693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
    Pfaller MA; Jones RN; Marshall SA; Coffman SL; Hollis RJ; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):211-9. PubMed ID: 9327251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of CTX-M-3 extended-spectrum beta-lactamase (ESBL) among cefotaxime-resistant Serratia marcescens at a medical center in middle Taiwan.
    Wu LT; Tsou MF; Wu HJ; Chen HE; Chuang YC; Yu WL
    Diagn Microbiol Infect Dis; 2004 Jun; 49(2):125-9. PubMed ID: 15183862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serratia marcescens bacteremia: clinical features and antimicrobial susceptibilities of the isolates.
    Yu WL; Lin CW; Wang DY
    J Microbiol Immunol Infect; 1998 Sep; 31(3):171-9. PubMed ID: 10496154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance of antimicrobial resistance in Serratia marcescens in Mexico.
    González GM; de J Treviño-Rangel R; Campos CL; Villanueva-Lozano H; Bonifaz A; Franco-Cendejas R; López-Jácome LE; Bobadilla Del Valle M; Llaca-Díaz JM; Ayala-Gaytán JJ; Castañón-Olivares LR; Tinoco JC; Andrade A
    New Microbiol; 2020 Jan; 43(1):34-37. PubMed ID: 32334489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
    Hsueh PR; Chen WH; Luh KT
    Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation of extended-spectrum beta-lactamase-producing Serratia marcescens: preliminary report from Taiwan.
    Yu WL; Wu LT; Pfaller MA; Winokur PL; Jones RN
    Diagn Microbiol Infect Dis; 2003 Apr; 45(4):221-4. PubMed ID: 12729989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KPC-PRODUCING Serratia marcescens IN A HOME-CARE PATIENT FROM RECIFE, BRAZIL.
    Margate E; Magalhães V; Fehlberg LC; Gales AC; Lopes AC
    Rev Inst Med Trop Sao Paulo; 2015; 57(4):359-60. PubMed ID: 26422164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA; Tawfik AF; Shibl AM
    Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.